Spring 2026 (In Press)
Back to the articles list |
Back to browse issues page
Golnaz Fallah1 
, Mehrdad Pashazadeh *2 , Abolfazl Jafari-Sales3 , Habib Tajalli4 , Seyedeh Samaneh Shahriar-oskouei5
, Mehrdad Pashazadeh *2 , Abolfazl Jafari-Sales3 , Habib Tajalli4 , Seyedeh Samaneh Shahriar-oskouei5
1- Department of Genetics, Ta.C., Islamic Azad University, Tabriz, Iran
2- Department of Medical Laboratory Sciences and Microbiology, TaMS.C., Islamic Azad University, Tabriz, Iran & Infectious Diseases Research Center, TaMS.C., Islamic Azad University, Tabriz, Iran ,Mehrdadpashazadeh85@gmail.com
3- Infectious Diseases Research Center, TaMS.C., Islamic Azad University, Tabriz, Iran & Department of Microbiology, Kaz.C., Islamic Azad University, Kazerun, Iran
4- Biophotonics Research Center, Ta.C., Islamic Azad University, Tabriz, Iran
5- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2- Department of Medical Laboratory Sciences and Microbiology, TaMS.C., Islamic Azad University, Tabriz, Iran & Infectious Diseases Research Center, TaMS.C., Islamic Azad University, Tabriz, Iran ,
3- Infectious Diseases Research Center, TaMS.C., Islamic Azad University, Tabriz, Iran & Department of Microbiology, Kaz.C., Islamic Azad University, Kazerun, Iran
4- Biophotonics Research Center, Ta.C., Islamic Azad University, Tabriz, Iran
5- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract: (23 Views)
Background & Objectives: Thyroid cancer is one of the most prevalent endocrine malignancies. Photodynamic therapy is an emerging minimally invasive therapeutic modality that employs a photosensitizer in conjunction with light irradiation to induce targeted cytotoxicity. The present study was designed to evaluate the effects of zinc phthalocyanine-mediated photodynamic therapy on the expression of immune checkpoint genes CD47 and SIGLEC15, as well as key genes involved in apoptotic pathways, in papillary thyroid cancer cells.
Materials & Methods: The human papillary thyroid cancer cell line B-CPAP was exposed to various concentrations of zinc phthalocyanine and subsequently irradiated using a 675 nm diode laser at a fluence of 24 J/cm². Cellular viability, reflecting mitochondrial metabolic activity, was assessed using the MTT assay. The relative mRNA expression levels of CD47, SIGLEC15, Caspase-3, Caspase-9 and Bcl-2 genes were quantified using quantitative real-time polymerase chain reaction.
Results: Zinc phthalocyanine-mediated photodynamic therapy markedly reduced the viability of B-CPAP cells. The treatment activated the intrinsic apoptotic pathway, as demonstrated by the significant upregulation of Caspase-3 and Caspase-9 transcripts alongside the downregulation of Bcl-2 expression. In addition, a statistically significant reduction in the mRNA expression levels of the immune checkpoint molecules CD47 and SIGLEC15 was observed following treatment.
Conclusion: The findings of this study provide novel evidence that zinc phthalocyanine-mediated photodynamic therapy simultaneously induces apoptosis while downregulating the critical immune checkpoints CD47 and SIGLEC15 in thyroid cancer cells. This dual mechanism of action underscores the therapeutic potential of photodynamic therapy as an effective strategy for enhancing antitumor efficacy through both direct cytotoxic effects and the potential mitigation of immune evasion.
Keywords: Thyroid cancer, Photodynamic therapy, Zinc phthalocyanine, Immune checkpoints, Apoptosis
CD47 and SIGLEC15 Immune Checkpoint Genes Expression and Apoptotic Pathway Activation Following Photodynamic Therapy with Zinc Phthalocyanine in the B-CPAP Thyroid Cancer Cell Line
Photodynamic Therapy, Immune Checkpoints, and Apoptosis in Thyroid Cancer
Background & Objectives: Thyroid cancer is one of the most prevalent endocrine malignancies. Photodynamic therapy is an emerging minimally invasive therapeutic modality that employs a photosensitizer in conjunction with light irradiation to induce targeted cytotoxicity. The present study was designed to evaluate the effects of zinc phthalocyanine-mediated photodynamic therapy on the expression of immune checkpoint genes CD47 and SIGLEC15, as well as key genes involved in apoptotic pathways, in papillary thyroid cancer cells.
Materials & Methods: The human papillary thyroid cancer cell line B-CPAP was exposed to various concentrations of zinc phthalocyanine and subsequently irradiated using a 675 nm diode laser at a fluence of 24 J/cm². Cellular viability, reflecting mitochondrial metabolic activity, was assessed using the MTT assay. The relative mRNA expression levels of CD47, SIGLEC15, Caspase-3, Caspase-9 and Bcl-2 genes were quantified using quantitative real-time polymerase chain reaction.
Results: Zinc phthalocyanine-mediated photodynamic therapy markedly reduced the viability of B-CPAP cells. The treatment activated the intrinsic apoptotic pathway, as demonstrated by the significant upregulation of Caspase-3 and Caspase-9 transcripts alongside the downregulation of Bcl-2 expression. In addition, a statistically significant reduction in the mRNA expression levels of the immune checkpoint molecules CD47 and SIGLEC15 was observed following treatment.
Conclusion: The findings of this study provide novel evidence that zinc phthalocyanine-mediated photodynamic therapy simultaneously induces apoptosis while downregulating the critical immune checkpoints CD47 and SIGLEC15 in thyroid cancer cells. This dual mechanism of action underscores the therapeutic potential of photodynamic therapy as an effective strategy for enhancing antitumor efficacy through both direct cytotoxic effects and the potential mitigation of immune evasion.
Keywords:
Materials & Methods: The human papillary thyroid cancer cell line B-CPAP was exposed to various concentrations of zinc phthalocyanine and subsequently irradiated using a 675 nm diode laser at a fluence of 24 J/cm². Cellular viability, reflecting mitochondrial metabolic activity, was assessed using the MTT assay. The relative mRNA expression levels of CD47, SIGLEC15, Caspase-3, Caspase-9 and Bcl-2 genes were quantified using quantitative real-time polymerase chain reaction.
Results: Zinc phthalocyanine-mediated photodynamic therapy markedly reduced the viability of B-CPAP cells. The treatment activated the intrinsic apoptotic pathway, as demonstrated by the significant upregulation of Caspase-3 and Caspase-9 transcripts alongside the downregulation of Bcl-2 expression. In addition, a statistically significant reduction in the mRNA expression levels of the immune checkpoint molecules CD47 and SIGLEC15 was observed following treatment.
Conclusion: The findings of this study provide novel evidence that zinc phthalocyanine-mediated photodynamic therapy simultaneously induces apoptosis while downregulating the critical immune checkpoints CD47 and SIGLEC15 in thyroid cancer cells. This dual mechanism of action underscores the therapeutic potential of photodynamic therapy as an effective strategy for enhancing antitumor efficacy through both direct cytotoxic effects and the potential mitigation of immune evasion.
Keywords: Thyroid cancer, Photodynamic therapy, Zinc phthalocyanine, Immune checkpoints, Apoptosis
CD47 and SIGLEC15 Immune Checkpoint Genes Expression and Apoptotic Pathway Activation Following Photodynamic Therapy with Zinc Phthalocyanine in the B-CPAP Thyroid Cancer Cell Line
Photodynamic Therapy, Immune Checkpoints, and Apoptosis in Thyroid Cancer
Background & Objectives: Thyroid cancer is one of the most prevalent endocrine malignancies. Photodynamic therapy is an emerging minimally invasive therapeutic modality that employs a photosensitizer in conjunction with light irradiation to induce targeted cytotoxicity. The present study was designed to evaluate the effects of zinc phthalocyanine-mediated photodynamic therapy on the expression of immune checkpoint genes CD47 and SIGLEC15, as well as key genes involved in apoptotic pathways, in papillary thyroid cancer cells.
Materials & Methods: The human papillary thyroid cancer cell line B-CPAP was exposed to various concentrations of zinc phthalocyanine and subsequently irradiated using a 675 nm diode laser at a fluence of 24 J/cm². Cellular viability, reflecting mitochondrial metabolic activity, was assessed using the MTT assay. The relative mRNA expression levels of CD47, SIGLEC15, Caspase-3, Caspase-9 and Bcl-2 genes were quantified using quantitative real-time polymerase chain reaction.
Results: Zinc phthalocyanine-mediated photodynamic therapy markedly reduced the viability of B-CPAP cells. The treatment activated the intrinsic apoptotic pathway, as demonstrated by the significant upregulation of Caspase-3 and Caspase-9 transcripts alongside the downregulation of Bcl-2 expression. In addition, a statistically significant reduction in the mRNA expression levels of the immune checkpoint molecules CD47 and SIGLEC15 was observed following treatment.
Conclusion: The findings of this study provide novel evidence that zinc phthalocyanine-mediated photodynamic therapy simultaneously induces apoptosis while downregulating the critical immune checkpoints CD47 and SIGLEC15 in thyroid cancer cells. This dual mechanism of action underscores the therapeutic potential of photodynamic therapy as an effective strategy for enhancing antitumor efficacy through both direct cytotoxic effects and the potential mitigation of immune evasion.
Keywords:
Type of Study: Research |
Subject:
Immunology
Received: 2025/12/14 | Revised: 2026/05/12 | Accepted: 2026/01/7
Received: 2025/12/14 | Revised: 2026/05/12 | Accepted: 2026/01/7
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |